This study is A prospective, randomized, double-blind, placebo-controlled study to compare the efficacy of Ashwagandha in stress disorder in healthy adults. A total of 50 healthy adults subjects will be recruited in this study. Adult male or female subjects between 18 to 60 years of age, with routine work stress, stress disorders characterized with difficulty in concentration, physical exhaustion, anxiety, restlessness, insomnia, headache, fatigue, loss of appetite, phobia, sweating, mental confusion etc. , Perceived Stress Scale (PSS) score more than or equal to 20 and Body mass index between 25 and 39.9 kg/m2 will be enroll in study. Study duration will be 8 weeks for each subject with baseline, week 4 & week 8 visits. Subjects were asked to take 1 capsule two times daily (total 2 capsules per day) with water daily for 8 weeks. At the end of study primary outcome will be assessed as Improvement from baseline in Perceived Stress Scale score (PSS) after therapy and secondary outcome as improvement from baseline in the score for Oxford Happiness Scale and urine cortisol level. Change in Weight, vital signs and Body mass index (BMI) and absolute and percentage weight loss will be compared after therapy.Safety will be assessed by evaluation of adverse events reported by the patients during the study and Global assessment of tolerability will be performed by physician at the end of study.